Efficacy and Tolerance of a Combination of Targeted Therapies Indicated for Asthma and Chronic Inflammatory Rheumatism. (PubMed, Joint Bone Spine) - Sep 20, 2026 - "This is the largest case series to date on dual targeted therapy for CIR and allergic asthma. Rheumatologic control was generally maintained, particularly when rheumatologic treatment was initiated first. Pulmonary infections were the main adverse events, highlighting the need for caution in patients with additional pulmonary comorbidities."
Journal • Ankylosing Spondylitis • Asthma • Immunology • Infectious Disease • Inflammation • Inflammatory Arthritis • Pulmonary Disease • Respiratory Diseases • Rheumatoid Arthritis • Rheumatology • Seronegative Spondyloarthropathies • Spondylarthritis • IL17A • IL5
|
|
Arnaud Bourdin; Arnaud Constantin; Baptiste Gerard; Benoit Flachaire; Cédric Lukas; Claire Daien; Claire Rempenault; Jacques Morel; Leo Etronnier; Martin Soubrier; Morgane Milin; Olivia Berthoud; Xavier Puéchal
|